Alanine aminotransferase (ALT) flares, defined as a sudden increase in ALT levels, are well known to occur frequently during interferon (IFN) based therapies in patients with hepatitis C and hepatitis B [1, 2, 3, 4, 5]. This evidence concerns the gene GPT and hepatitis B virus infection.